Artificial intelligence (AI) and machine learning (ML) are ideal "power tools” for drug discovery and development. Leaders across big pharma and emerging biotech’s with platforms grounded in AI/ML will describe how these technologies have been fundamental to their business strategy, enabling the efficiency and scale of their drug discovery and helping raise financings and drive partnerships.